Electroceuticals: Technologies and Global Markets

Report Highlights

The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.

Report Includes

• 19 data tables and 24 additional tables
• An overview of global markets and technologies for electroceuticals
• Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
• Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
• Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
• Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
• Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
• Company profiles of major players within the industry, including Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc and Edwards Lifesciences Corp.

Report Scope

This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.

This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.

For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
• Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
• Induced Pluripotent Stem Cells: Global Markets (BIO135F)
• Commercial Amino Acids (BIO007N)
• Technical Textiles: Global Markets (CHM136C)